1. Home
  2. NTRA

as 11-12-2024 4:00pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Founded: 2003 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 15.3B IPO Year: 2015
Target Price: $129.40 AVG Volume (30 days): 938.0K
Analyst Decision: Strong Buy Number of Analysts: 16
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.44 EPS Growth: N/A
52 Week Low/High: $49.97 - $140.00 Next Earning Date: 11-12-2024
Revenue: $1,360,503,000 Revenue Growth: 46.13%
Revenue Growth (this year): 42.99% Revenue Growth (next year): 13.31%

NTRA Daily Stock ML Predictions

Stock Insider Trading Activity of Natera Inc. (NTRA)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Moshkevich Solomon NTRA PRESIDENT, CLINICALDIAGNOSTICS Oct 28 '24 Sell $118.21 1,196 $141,379.76 110,695
RABINOWITZ DANIEL NTRA SEC. AND CHIEF LEGAL OFFICER Oct 28 '24 Sell $118.21 1,057 $124,948.50 206,027
Chapman Steven Leonard NTRA CEO AND PRESIDENT Oct 28 '24 Sell $118.21 3,960 $468,113.58 189,762
Brophy Michael Burkes NTRA CHIEF FINANCIAL OFFICER Oct 24 '24 Sell $119.00 1,605 $191,037.37 72,709
Brophy Michael Burkes NTRA CHIEF FINANCIAL OFFICER Oct 22 '24 Sell $119.09 496 $59,068.49 72,709
Moshkevich Solomon NTRA PRESIDENT, CLINICALDIAGNOSTICS Oct 21 '24 Sell $120.41 550 $66,241.10 110,695
RABINOWITZ DANIEL NTRA SEC. AND CHIEF LEGAL OFFICER Oct 20 '24 Sell $120.41 816 $98,298.04 206,027
Brophy Michael Burkes NTRA CHIEF FINANCIAL OFFICER Oct 20 '24 Sell $120.41 1,062 $127,932.28 72,709
Chapman Steven Leonard NTRA CEO AND PRESIDENT Oct 20 '24 Sell $120.41 2,602 $313,597.08 189,762
Chapman Steven Leonard NTRA CEO AND PRESIDENT Oct 15 '24 Sell $130.40 4,523 $589,796.94 189,762

Share on Social Networks: